TickerFacts.

Vitaspring Biomedical Co. Ltd. (VSBC): EPS (Diluted)

Annual figures by period end, from SEC filings.

$0.00
Year ended 2026-01-31
2022-01-31: $0.002023-01-31: -$0.022024-01-31: -$0.012025-01-31: $0.002026-01-31: $0.00$0.00
2022-01-31 EPS (Diluted) (USD per share) 2026-01-31
Period endedEPS (Diluted)Change YoYSource filing
2026-01-31$0.00n/a2026-06-17, From 2025-02-01
2025-01-31$0.00n/m2026-06-17, From 2024-02-01
2024-01-31-$0.01n/m2026-06-08, From 2023-02-01
2023-01-31-$0.02n/a2026-03-12, From 2022-02-01
2022-01-31$0.00n/a2025-12-01, From 2021-02-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31$0.00n/a
NRC Health (NRC)2025-12-31$50.00n/m
Incyte Corp (INCY)2025-12-31$6.41n/m
Icon PLC (ICLR)2025-12-31$2.90-67.4%
Charles River Laboratories International, Inc. (CRL)2025-12-27-$2.91n/m
MaxCyte, Inc. (MXCT)2025-12-31-$0.42n/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$0.00n/m
Iqvia Holdings Inc. (IQV)2025-12-31$7.84+4.7%
iSpecimen Inc. (ISPC)2025-12-31-$2.28n/m

Compare VSBC, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗